Table 1.
Characteristics of the included studies.
| Authors | Study Design | Number of Subjects | Age (Mean/Median) (Years) | Female | Hypertension | Diabetes Mellitus | Cardiovascular Diseases | Periprocedural Complications | Undergo Surgery (%) | Thromboembolic Events (%) | Mortality (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Egol (2020) | Prospective Cohort | 17 vs 107 | 82.4 vs 83.4 | 5/17 vs 73/107 | 11/17 vs 67/107 | 7/17 vs 20/107 | 8/17 vs 40/107 | Sepsis, bacterial pneumonia, viral pneumonia, DVT/PE, MI, stroke, acute respiratory failure, cardiac arrest, AKI, decubitus ulcer, UTI, anemia, hypotension, atrial fibrillation | 76.5 vs 100 | 11.8 vs 2.8 | 35.3 vs 0.9 |
| LeBrun (2020) | Retrospective Cohort | 9 vs 40 | 86.5 vs 84.7 | 6/9 vs 38/40 | N/A | 3/9 vs 14/40 | 1/9 vs 8/40 (MI) | Pneumonia (any cause), DVT/PE, stroke, MI, cardiac arrhythmia, UTI, decubitus ulcer, anemia, acute respiratory failure | 78 vs 100 | N/A | 56 vs 4 |
| Vives (2020) | Retrospective Cohort | 23 vs 39 | 87 vs 85.2∗ | 8/13 vs 94/123∗ | N/A | N/A | N/A | N/A | 38.5 vs 96.7∗ | N/A | 30.4 vs 10.3 |
| Cheung (2020) | Retrospective Cohort | 10 vs 0 | 79.7 vs 0 | 8/10 vs 0/0 | 7/10 vs 0/0 | 3/10 vs 0/0 | 2/10 vs 0/0 | Atypical pneumonia, anemia, blood transfusion, VTE, prolonged hypoxia requiring supplemental O2, respiratory failure, AKI | 100 vs 0 | 1/10 vs 0/0 | 10 vs 0 |
| Hall (2020) | Retrospective Cohort | 27 vs 290 | 83.6 vs 80.4 | 13/27 vs 198/290 | N/A | N/A | N/A | N/A | 92.6 vs 95.9 | N/A | 33.3 vs 82.8 |
| Kayani (2020) | Retrospective Cohort | 82 vs 340 | 71.9 vs 72.7 | 51/82 vs 204/340 | N/A | N/A | N/A | Respiratory infection, AKI, septic shock, MI, ARDS, multiorgan dysfunction, severe metabolic acidosis, coagulation dysfunction | 100 vs 100 | N/A | 30.5 vs 10.3 |
∗compares non-survivor group vs survivor group.
This table compares COVID-19 (+) group vs COVID-19 (−) group.
DVT/PE: Deep venous thrombosis/Pulmonary embolism; MI: Myocardial infarction; AKI: Acute kidney injury; UTI: Urinary tract infection; VTE: Venous thromboembolism.